| SMITH & NEPHEW |
| Großbritannien |
| Gesundheit |
| GB0009223206 / 502816 |
| NPW1 (Frankfurt) |
| FRA:NPW1, ETR:NPW1, NPW1:GR |
| FTSE100 |
| https://www.smith-nephew... |
|
Smith & Nephew plc is a British multinational medical technology company specializing in the repair, regeneration, and replacement of soft and hard tissue. Headquartered in Watford, England, it develops and manufactures advanced products across three..
>Volltext.. |
| 11659.43 Mio. EUR |
| 14021.64 Mio. EUR |
| 5465.49 Mio. EUR |
| 1424.08 Mio. EUR |
| 553.97 Mio. EUR |
| 0.64 EUR |
| 2891.52 Mio. EUR |
| 484.09 Mio. EUR |
| 1121.76 Mio. EUR |
| 0.35 |
| -2.39% |
| 39.42% |
| 0.34 EUR |
| 2.44% |
| 2.42% |
| 26.03.26 - 0.20894699€ 02.10.25 - 0.1287€ >weitere anzeigen... |
| - |
| SMITH & NEPHEW, SMITHNEPHEW, SMITH NEPHEW, SMITH&NEPHEW |
| 04.08.26 |
|
||||
|
||||
|
||||
|